(New York, NY – March 1, 2018) PulsePoint, the leading global authority in programmatic healthcare technology, today announced its ability to track user consent in connection with the processing of personal data across its ad exchange, well ahead of the May 25, 2018, effective date of the General Data Protection Regulation (GDPR). All client-side and server-side connection points have been updated. In addition, PulsePoint announced a GDPR-ready header bidder wrapper.
PulsePoint’s exchange and header bidder wrapper recognize whether a user has or has not consented to the processing of their personal data for delivering advertising. This information is passed along to ad buyers. PulsePoint also utilizes this this consent tracking for its own buying platform and Private Marketplace solutions.
“PulsePoint firmly supports all initiatives to improve transparency regarding the use of personal data,” said Sloan Gaon, CEO of PulsePoint. “Creating trusted, positive ad experiences has always been critical to PulsePoint, and this is even more relevant as we focus on delivering meaningful programmatic health offerings that resonate with both consumers and healthcare practitioners.
PulsePoint’s long-standing commitment to delivering a leading ad experience for consumers has led to its quick adoption of the IAB Europe’s OpenRTB GDPR user consent Advisory. To facilitate publisher’s consent tracking, PulsePoint has also created a turnkey GDPR-consent solution which can be deployed on publisher pages with minimal effort. The tool accepts consent preferences from users and allows publishers to pass this information along to their advertising demand sources.
“PulsePoint is proud to be a leader in innovative, forward-looking solutions,” said Ezra Suveyke, PulsePoint’s CTO. “As we advance programmatic healthcare technology, we are committed to building products that deliver data transparency and drive improved user experience. “
For more information about PulsePoint click here.
PulsePoint, a global programmatic advertising platform with specialized healthcare expertise, fuses the science of programmatic targeting, distribution and optimization with the art of brand engagement. The PulsePoint platform is powered by terabytes of impression-level data, allowing brands to efficiently engage the right audiences at scale while helping publishers increase yield through actionable insights. Investors in the company include Draper Fisher Jurvetson (DFJ), Gotham Ventures, New Atlantic Ventures (NAV), Investor Growth Capital, Updata Partners and VantagePoint Capital Partners. The company is headquartered in New York City with offices in San Francisco, California, and London, U.K. Learn more about PulsePoint here.
Sylvie Calman for PulsePoint
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form